Abpro Holdings Inc (ABP)

$5.49 -0.40 (-6.71%)
Market Cap 14.66M
Revenue (ttm) 180,000.00
Net Income (ttm) -7.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,016.67%
Debt to Equity Ratio 0.00
Volume 31,600
Avg Vol 208,031
Day's Range N/A - N/A
Shares Out 2.67M
Stochastic %K 28%
Beta 0.01
Analysts Hold
Price Target $2.00

Company Profile

Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific anti...

Industry: Biotechnology
Sector: Healthcare
Phone: 800-396-5890
Website: abpro.co
Address:
68 Cummings Park Drive, Woburn, United States
_Verticality
_Verticality Nov. 14 at 9:50 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $ABP $NCEL $NVA $ENVB z
0 · Reply
_SquidGains_
_SquidGains_ Nov. 13 at 11:31 PM
$ABP $NCEL $NVA $ENVB .
0 · Reply
devilartist
devilartist Nov. 13 at 5:32 AM
$ABP Abprobio's stock price in Korea soared 130% ($0.12 to $0.3) thanks to its collaboration with Celtrion. Is there no news about ABP?
1 · Reply
f1rew1re
f1rew1re Nov. 12 at 7:34 PM
$ABP breakout failed - waiting…
0 · Reply
Diggersen
Diggersen Nov. 12 at 6:26 PM
$ABP Squeeze it
0 · Reply
Learninghow
Learninghow Nov. 12 at 6:13 PM
$ABP keeps setting up
0 · Reply
Learninghow
Learninghow Nov. 11 at 12:45 AM
$ABP this is setting up 🆙
0 · Reply
f1rew1re
f1rew1re Nov. 10 at 5:58 PM
$ABP silence again…
1 · Reply
YermiyahRenata
YermiyahRenata Nov. 10 at 12:01 PM
$ABP ABP will 10X!!! The only question is WHEN!!! 💎💎💎 SITC's 40th Anniversary Annual Meeting & Pre-Conference Programs was this past weekend and was held in National Harbor, MD. ABP-102/CT-P72 Data: ABPRO and its partner CELLTRION presented PRECLINICAL data at SITC 2025 for ABP-102/CT-P72. The data showed potent anti-tumor activity against HER2+ cancers and supported its advancement toward clinical DEVELOPMENT. The antibody was engineered to reduce cytokine-related toxicities, a common side effect in similar therapies. So far their research sounds extremely FAVORABLE and PROMISING!! SO.................. If the CEO is Fueling UP, I am as well with INSIDERS!!! Don't miss OUT on a potential BILLION dollar + DEAL!!! 🫣👀🚀
0 · Reply
MEHAILEB
MEHAILEB Nov. 10 at 6:44 AM
$ABP Great science was presented in American Association for Cancer Research (AACR)
0 · Reply
Latest News on ABP
Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager

Nov 4, 2025, 9:15 AM EST - 11 days ago

Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager

Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025

Nov 3, 2025, 7:00 AM EST - 12 days ago

Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025

Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager

Apr 27, 2025, 2:00 PM EDT - 7 months ago

Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager

Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

Mar 25, 2025, 4:30 PM EDT - 8 months ago

Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

Abpro Statement on the Departure of Former CEO Ian Chan

Mar 10, 2025, 6:34 PM EDT - 8 months ago

Abpro Statement on the Departure of Former CEO Ian Chan

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing

Dec 12, 2024, 4:05 PM EST - 1 year ago

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing

_Verticality
_Verticality Nov. 14 at 9:50 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $ABP $NCEL $NVA $ENVB z
0 · Reply
_SquidGains_
_SquidGains_ Nov. 13 at 11:31 PM
$ABP $NCEL $NVA $ENVB .
0 · Reply
devilartist
devilartist Nov. 13 at 5:32 AM
$ABP Abprobio's stock price in Korea soared 130% ($0.12 to $0.3) thanks to its collaboration with Celtrion. Is there no news about ABP?
1 · Reply
f1rew1re
f1rew1re Nov. 12 at 7:34 PM
$ABP breakout failed - waiting…
0 · Reply
Diggersen
Diggersen Nov. 12 at 6:26 PM
$ABP Squeeze it
0 · Reply
Learninghow
Learninghow Nov. 12 at 6:13 PM
$ABP keeps setting up
0 · Reply
Learninghow
Learninghow Nov. 11 at 12:45 AM
$ABP this is setting up 🆙
0 · Reply
f1rew1re
f1rew1re Nov. 10 at 5:58 PM
$ABP silence again…
1 · Reply
YermiyahRenata
YermiyahRenata Nov. 10 at 12:01 PM
$ABP ABP will 10X!!! The only question is WHEN!!! 💎💎💎 SITC's 40th Anniversary Annual Meeting & Pre-Conference Programs was this past weekend and was held in National Harbor, MD. ABP-102/CT-P72 Data: ABPRO and its partner CELLTRION presented PRECLINICAL data at SITC 2025 for ABP-102/CT-P72. The data showed potent anti-tumor activity against HER2+ cancers and supported its advancement toward clinical DEVELOPMENT. The antibody was engineered to reduce cytokine-related toxicities, a common side effect in similar therapies. So far their research sounds extremely FAVORABLE and PROMISING!! SO.................. If the CEO is Fueling UP, I am as well with INSIDERS!!! Don't miss OUT on a potential BILLION dollar + DEAL!!! 🫣👀🚀
0 · Reply
MEHAILEB
MEHAILEB Nov. 10 at 6:44 AM
$ABP Great science was presented in American Association for Cancer Research (AACR)
0 · Reply
NiX2000
NiX2000 Nov. 7 at 10:35 PM
$ABP massive dilution coming. Any co that works with YA go to OTC.
1 · Reply
drwaz
drwaz Nov. 4 at 7:50 PM
$ABP Everything is manipluated. What a joke
0 · Reply
f1rew1re
f1rew1re Nov. 4 at 7:11 PM
$ABP not what I expected after the gap has been closed but it seems the overall market is red today…
1 · Reply
_www_larval_com_
_www_larval_com_ Nov. 4 at 4:41 PM
$ABP has turned -4% lower to 2% (~3Mv) moments ago, follow for more volatility.
0 · Reply
Bioluminescent
Bioluminescent Nov. 4 at 4:39 PM
$ABP gap filled. Let's rock
1 · Reply
THINKOUTOFBOX
THINKOUTOFBOX Nov. 4 at 3:49 PM
$ABP For anyone who doesn’t realize the kind of backup we’ve got here: Celltrion is worth over $28 B on the Korean stock market, while we’re sitting at only $15 M market cap. That difference isn’t something you just ignore. Their partnership alone could easily be a major catalyst for this stock. it’s just my opinion — everyone can be wrong. GLTA!
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 3:11 PM
Abpro Corporation shares rose after the company announced that its bispecific HER2/CD3 antibody, developed with Celltrion, was selected among the top 150 abstracts for the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting. The therapy, CT-P72/ABP-102, showed strong antitumor activity in preclinical studies, including efficacy against tumors resistant to Enhertu. It demonstrated selective binding to tumor cells with high HER2 expression while minimizing activity in normal tissues, suggesting an improved safety profile. CEO Miles Suk said the antibody exhibited potent activity and high selectivity in HER2-overexpressing and Enhertu-resistant models, maintaining favorable safety in nonhuman primates. Preclinical data will be presented at SITC 2025 in Maryland, with plans to move into human trials next year targeting HER2-positive breast, gastric, colorectal, and other solid tumors. $ABP
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 3:05 PM
$ABP sector heating up... stay tuned!
0 · Reply
JesterOfWallSt
JesterOfWallSt Nov. 4 at 2:43 PM
$ABP Last Call! 🚀🚀🚀 $DTCK $HKD $YYAI
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 4 at 2:43 PM
🪙 🚀 $ABP up ⬆️13.62% since our entry $0.1901 on Oct 31, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
JesterOfWallSt
JesterOfWallSt Nov. 4 at 2:41 PM
$ABP Micro 1.78m Float 🚀 $SRPU $CAPT $PTLE
0 · Reply
GREENJMB81
GREENJMB81 Nov. 4 at 2:40 PM
$ABP Any chance we see $8.50 again... Shoulda sold.
0 · Reply